SWITCH BIOTECH AG
SWITCH Biotech uses its broad knowledge and expertise of the molecular biology of the skin to develop drugs for various skin disorders.
SWITCH BIOTECH AG
Industry:
Biotechnology Medical
Founded:
2008-01-01
Address:
Conway, Arkansas, United States
Country:
United States
Website Url:
http://www.switch-biotech.com
Total Employee:
1+
Status:
Active
Contact:
501-658-8269
Email Addresses:
[email protected]
Technology used in webpage:
South African Server Location
Similar Organizations
Abound Bio
Abound Bio specializes in generating antibody-based biological therapeutics to meet medical needs in the fields of cancer.
Biorealize
Biorealize is a design, research, and manufacturing company that builds tools that make it easy to access biodesign
Founder
Official Site Inspections
http://www.switch-biotech.com
- Host name: 172.65.190.172
- IP address: 172.65.190.172
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Switch Biotech AG"
Revolutionizing RNAi Therapies | Switch Therapeutics
Switch Therapeutics is a biotech company dedicated to revolutionizing RNA interference (RNAi) therapies with conditionally activated siRNAs (CASi). ... At Switch, we value an environment built on scientific values to promote …See details»
Switch Biotech LLC - Drug pipelines, Patents, Clinical trials - Synapse
Explore Switch Biotech LLC with its drug pipeline, therapeutic area, technology platform, , Drug:SWT-02.100, SWT-01100, SWT-05141, SWT-06101, SWT-01113. ... The statistics for …See details»
Meet Our Team - Switch Therapeutics
Charles joins Switch Therapeutics after dedicating more than 20 years of his career building nucleic acid chemical tools and applying them to the development of RNA-based therapeutics. …See details»
Switch Bioworks
Through a proprietary mechanism, microbes then switch on nitrogen fertilizer production. Led by Tim Schnabel, the Switch Bioworks team is made up of almost exclusively scientists and …See details»
Switch Therapeutics - Crunchbase Company Profile
Switch Therapeutics is a biotech company that develops RNAi therapies based on technology. The company was founded in 2020 and is based in San Francisco, California, United States. ... 4,416 Number of Organizations • …See details»
SWITCH Biotech - Products, Competitors, Financials, Employees ...
SWITCH Biotech uses its knowledge and expertise of the molecular biology of the skin to develop drugs for various skin disorders. The company provides potential new and re-profile existing …See details»
Switch Biotech AG - BioCentury Company Profiles - BCIQ
Jul 26, 2004 Switch Biotech AG - BioCentury Company Profiles for the biopharma industrySee details»
About Our Research and Scientists | Switch Therapeutics
Switch Therapeutics was founded in 2020 to develop therapeutic applications from RNAi research conducted at Caltech, Harvard Medical School and City of Hope. In early 2022, Switch …See details»
Switch Therapeutics launches with $52M to capitalize on RNA …
Mar 14, 2023 Switch plans to develop small interfering RNA structures that could attach to a sensor and target specific cells. The company is named for its goal of developing cell-specific …See details»
Switch Therapeutics Announces Formation of Scientific Advisory …
Jun 1, 2023 Switch Therapeutics is an emerging biotechnology company pioneering a new type of medicine that integrates nucleic acid nanotechnology and RNA interference (RNAi) science, …See details»
Eli Lilly, UCB and others Switch into gear with $52M for new RNA …
Mar 14, 2023 South San Francisco biotech Switch Therapeutics unwrapped Tuesday morning with $52 million to finance conditionally activated siRNA molecules.See details»
Switch Therapeutics Expands Leadership Team with Key …
SOUTH SAN FRANCISCO, Calif. – March 28, 2023 – Switch Therapeutics, a preclinical stage biotechnology company pioneering a new way to use RNA science to treat diseases, today …See details»
Switch Therapeutics Appoints Charles Allerson, Ph.D., as Chief ...
Jan 3, 2024 — Veteran RNA expert, oligonucleotide chemist and biotech industry expert, Charles Allerson, Ph.D., joins Switch Therapeutics from DTx Pharma to lead the acceleration …See details»
Switch Therapeutics Comes Out of Stealth to Advance First-of-its …
Mar 14, 2023 Switch was founded by Datta and Si-ping Han, now CTO, in 2020 and is based on many years of research on RNAi by Caltech professor Bill Goddard; City of Hope molecular …See details»
Switch Therapeutics Launches with $52 Million to Advance First-of …
Switch was founded on the premise of a new type of RNA medicine that integrates nucleic acid nanotechnology and RNA interference (RNAi) science. Based on the scientific discovery of its …See details»
Editor’s pick: Switch Therapeutics | Nature Biotechnology
Oct 14, 2024 Switch Therapeutics is rethinking cell-type specificity, building precision RNAi therapeutics for the brain. Nature Biotechnology - Each year, Nature Biotechnology highlights …See details»
Switch Therapeutics Launches to Develop Targeted siRNA Therapies
Mar 14, 2023 RNA therapeutics biotech Switch Therapeutics came out of stealth mode this week announcing $52M in early funding to develop conditionally activated small interfering (CASi) …See details»
Switch Therapeutics launches with $52M to capitalize on RNA …
With an aim to make more precise genetic medicines, Switch Therapeutics emerged from stealth Tuesday with $52 million in venture funding. Switch is built on research into what it describes …See details»
News - Switch Therapeutics
Dee Datta, Ph.D., co-founder and CEO of Switch Therapeutics, will participate in a virtual fireside chat at the Evercore ISI 2024 Emerging Biotech Conference… Read More Switch …See details»